pathTiMEx: Joint Inference of Mutually Exclusive Cancer Pathways and Their Dependencies in Tumor Progression
暂无分享,去创建一个
[1] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[2] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[3] William M. Rand,et al. Objective Criteria for the Evaluation of Clustering Methods , 1971 .
[4] J. Lagergren,et al. Learning Oncogenetic Networks by Reducing to Mixed Integer Linear Programming , 2013, PloS one.
[5] F. Markowetz,et al. Cancer Evolution: Mathematical Models and Computational Inference , 2014, Systematic biology.
[6] Camille Roth,et al. Natural Scales in Geographical Patterns , 2017, Scientific Reports.
[7] Benjamin J. Raphael,et al. CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer , 2015, Genome Biology.
[8] Upender Manne,et al. Prognostic value of mucin 4 expression in colorectal adenocarcinomas , 2010, Cancer.
[9] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[10] Jens Lagergren,et al. New Probabilistic Network Models and Algorithms for Oncogenesis , 2006, J. Comput. Biol..
[11] Nicholas Eriksson,et al. Conjunctive Bayesian networks , 2006, math/0608417.
[12] L. Trusolino,et al. Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils , 2011, EMBO molecular medicine.
[13] Guanming Wu,et al. Manic fringe promotes a claudin-low breast cancer phenotype through notch-mediated PIK3CG induction. , 2015, Cancer research.
[14] I. Weinstein. Addiction to Oncogenes--the Achilles Heal of Cancer , 2002, Science.
[15] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[16] Ramon Diaz-Uriarte,et al. Identifying restrictions in the order of accumulation of mutations during tumor progression: effects of passengers, evolutionary models, and sampling , 2015, BMC Bioinformatics.
[17] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[18] M. Levandowsky,et al. Distance between Sets , 1971, Nature.
[19] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[20] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[21] Giancarlo Mauri,et al. CAPRI: Efficient Inference of Cancer Progression Models from Cross-sectional Data , 2014, bioRxiv.
[22] C. Sander,et al. Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations , 2014 .
[23] Benjamin J. Raphael,et al. Simultaneous Inference of Cancer Pathways and Tumor Progression from Cross-Sectional Mutation Data , 2015, J. Comput. Biol..
[24] Camille Stephan-Otto Attolini,et al. A mathematical framework to determine the temporal sequence of somatic genetic events in cancer , 2010, Proceedings of the National Academy of Sciences.
[25] Giancarlo Mauri,et al. Efficient inference of cancer progression models , 2014 .
[26] Eytan Ruppin,et al. Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality , 2014, Cell.
[27] Teresa M. Przytycka,et al. MEMCover: integrated analysis of mutual exclusivity and functional network reveals dysregulated pathways across multiple cancer types , 2015, Bioinform..
[28] Eli Upfal,et al. De Novo Discovery of Mutated Driver Pathways in Cancer , 2011, RECOMB.
[29] D. Rubin,et al. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .
[30] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[31] Niko Beerenwinkel,et al. Modeling Mutual Exclusivity of Cancer Mutations , 2014, RECOMB.
[32] Niko Beerenwinkel,et al. Efficient sampling for Bayesian inference of conjunctive Bayesian networks , 2012, Bioinform..
[33] M. Stratton,et al. The cancer genome , 2009, Nature.
[34] Niko Beerenwinkel,et al. Quantifying cancer progression with conjunctive Bayesian networks , 2009, Bioinform..
[35] Giancarlo Mauri,et al. Inferring Tree Causal Models of Cancer Progression with Probability Raising , 2013, bioRxiv.
[36] Seth Sullivant,et al. Markov models for accumulating mutations , 2007, 0709.2646.
[37] E. Fearon. Molecular genetics of colorectal cancer. , 2011, Annual review of pathology.
[38] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[39] Roded Sharan,et al. Simultaneous Identification of Multiple Driver Pathways in Cancer , 2013, PLoS Comput. Biol..
[40] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[41] Feng Jiang,et al. Inferring Tree Models for Oncogenesis from Comparative Genome Hybridization Data , 1999, J. Comput. Biol..
[42] Franziska Michor,et al. A Mathematical Methodology for Determining the Temporal Order of Pathway Alterations Arising during Gliomagenesis , 2012, PLoS Comput. Biol..
[43] J. York,et al. Bayesian Graphical Models for Discrete Data , 1995 .
[44] Benjamin J. Raphael,et al. Abstract 1936: CoMEt: A statistical approach to identify combinations of mutually exclusive alterations in cancer , 2015 .
[45] Nicholas Eriksson,et al. The Temporal Order of Genetic and Pathway Alterations in Tumorigenesis , 2011, PloS one.
[46] C. D. Gelatt,et al. Optimization by Simulated Annealing , 1983, Science.
[47] C. Sander,et al. Mutual exclusivity analysis identifies oncogenic network modules. , 2012, Genome research.
[48] Niko Beerenwinkel,et al. TiMEx: a waiting time model for mutually exclusive cancer alterations , 2015, Bioinform..